CARD15 gene polymorphisms in Serbian patients with Crohn's disease: Genotype-phenotype analysis

European Journal of Gastroenterology and Hepatology

Volumn 20, Issue 10, 2008, Pages 978-984

  Protic, Marijana B ^a,f   Pavlovic, Sonja T ^b   Bojic, Daniela Z ^a   Krstic, Miodrag N ^c   Radojicic, Zoran A ^d   Tarabar, Dino K ^e   Stevanovic, Ana Z ^b   Djurasevic, Teodora Z Karan ^b   Godjevac, Mina V ^b   Svorcan, Petar V ^a   Dapcevic, Branka D ^a   Jojic, Njegica Z ^a  

^a Center for Gastroenterology and Hepatology

^b Institute of Molecular Genetics and Genetic Engineering

^c University Clinical Center of Serbia

^d UNIVERSITY OF BELGRADE   (Serbia)

^e UNIVERSITY OF DEFENCE   (Serbia)

^f Clinical Centre Zvezdara   (Serbia)

Author keywords

CARD15 gene; Crohn's disease; Genotype phenotype analysis

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15;

ADULT; AGED; ALLELE; ARTICLE; CHI SQUARE TEST; CONTROLLED STUDY; CROHN DISEASE; FEMALE; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC RISK; GENOTYPE PHENOTYPE CORRELATION; HETEROZYGOTE; HUMAN; ILEUM; INTESTINAL FIBROSIS; INTESTINE STENOSIS; MAJOR CLINICAL STUDY; MALE; MUTANT; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SERBIA; STUDENT T TEST; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; COLITIS, ULCERATIVE; CROHN DISEASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NOD2 SIGNALING ADAPTOR PROTEIN; PHENOTYPE; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 53549127562     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e328302f45e     Document Type: Article

References (52)

1. Bartel G, Weis I, Turetsche K, Schima W, Puspok A, Waldhoer T, Gache C. Ingested matter affects intestinal lesions in Crohn's disease. Inflamm Bowel disease 2008; 14:374-382 [Epub ahead of print].
2. Schmidt C, Stallmach A. Etiology and pathogenesis of inflammatory bowel disease. Minerva Gastroenterol Dietol 2005; 51:127-145.
3. Karlinger K, Gyorke T, Mako E, Mester A, Tarjan Z. The epidemiology and the pathogenesis of inflammatory bowel disease. Eur J Radiol 2000; 35:154-167.
4. Loftus EV Jr, Sandborn WJ. Epidemiology of inflammatory bowel disease. Gastroenterol Clin North Am 2002; 31:1-20.
5. Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L, van Blankenstein M. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC- IBD). Gut 1996; 39:690-697.
6. Arnott IDR, Nimmo ER, Drummond HE, Fennell J, Smith BRK, MacKinlay E, et al. NOD2/CARD 15, TRL4 and CD14 mutation in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe? Genes Immun 2004; 5:417-425.
7. Inoue N, Tamura K, Kinouchi Y, Fukuda Y, Takahashi S, Ogura Y, et al. Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology 2002; 123:86-91.
8. Leong RW, Armuzzi A, Ahmad T, Wong ML, Tse P, Jewel DP, et al. NOD2/ CARD 15 gene polymorphism and Crohn's disease in the Chinese population. Aliment Pharmacol Ther 2003; 17:1465-1470.
9. Orholm M, Binder V, Sorensen Tl, Rasmussen LP, Kyvik KO. Concordance of inflammatory bowel disease among Danish twins. Results of nationwide study. Scand J Gastroenterol 2000; 35:1075-1081.
10. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP Belaiche J, et al. Association of NOD2 leucine rich repeat variants with susceptibility to Crohn's disease. Nature 2001 ; 411:599-603.
11. Ogura Y, Inohara N, Benito A, Chen FF, Yamaoka S, Ninez G. Nod 2, a Nod 1/Apaf-1 family member that is restricted to monocytes and activates NF- kappa B. J Biol Chem 2001; 276:4812-4818.
12. Lesage S, Zouali H, Cezard JP, Colombel JP, Belaiche J, Aimer S, et al. CARD 15/NOD 2 mutational analyses and genotype- phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002; 70:845-857.
13. Hugot JP, Zaccaria I, Cavanaugh J, Yang H, Vermeire S, Lappalainen M, et al. Prevalence of CARD15/NOD2 mutations in Caucasian healthy people. Am J Gastroenterol 2007; 102:1259-1267.
14. Economou M, Trikalinos TA, Loizou KT, Tsianos EV, loannidis J P. Differential effect of NOD2 variants on Crohn's disease risk and phenotype in diverse populations. Am J Gastroenterol 2004; 99:2393-2404.
15. Ahmad T, Tamboli PC, Jewel D, Colombel JF. Clinical relevance of Advances in Genetic and Pharmacogenetics of IBD. Gastroenterology 2004; 126:1533-1549.
16. Yamazaki K, Onouchi Y, Takazoe M, Kubo M, Nakamura Y, Hata A. Association analysis of genetic variants in IL23R, ATG16L1 and 5p13.1 loci with Crohn's disease in Japanese patients. J Hum Genet 2007; 52:575-583.
17. Bonen DK, Nicolae DL, Moran T, Turkyilmaz MA, Ramos R, Karaliukas R, et al. Racial differences in NOD2 variation: characterization of NOD2 in African American with Crohn's disease. Gastroenterology 2002; 122 (Suppl):A29.
18. Heliö T, Halme L, Lappalainen M, Fodstad H, Paavola-Sakki P, Turunen U, et al. CARD 15/NOD2 gene variants are associated with family occurring and complicated forms of Crohn's disease. Gut 2003; 52:558-562.
19. Bairead E, Harmon DL, Curtis AM, Kelly Y, O'Leary C, Gardner M, et al. Association of NOD2 with Crohn's disease in homogenous Irish population. Eur J Hum Gen 2003; 11:237-244.
20. Cukovic-Cavka S, Vermeire S, Hrstic I, Claessens Q, Kolacek S, Jakic-Razumovic J, Krznaric Z NOD2/CARD 15 mutations in Croatians patients with Crohn's disease: prevalence and genotype - phenotype relationship. Eur J Gastroenterohepatol 2006; 18:895-899.
21. Mendoza JL, Murillo LS, Fernandez L, Pena SA, Lana R, Urcelay E, et al. Prevalence of the NOD2/CARD 15 gene and relation to phenotype in Spanish patients with Crohn Disease. Scand J Gastroenterol 2003; 12:1235-1240.
22. Vavassori P, Borgiani P, Biancone L, D'Apice MR, Blanco Gdel V, Vallo L, et al. Card 15 mutations in an Italian population: Leu 1007fsinsC but neither Arg702Trp nor Gly908Arg mutations are associated with Crohn's disease. Inflamm Bowel Dis 2004; 10:116-121.
23. Bianchi V, Maconi G, Ardizzone S, Colombo E, Ferrara E, Russo A, et al. Association of NOD2/Card 15 mutations on Crohn's disease phenotype in an Italian population. Eur J Gastroenterol 2007; 19:217-223.
24. Braudel F. Mediterranean and the Mediterranean world. Los Angeles: California University press; 1995.
25. Stavrianos L The Balkans since 1453. New York: University Press; 2000.
26. Pavlovic S, Urosevic J, Poznanic J, Prisic LI, Petrucev B, Tosic N, et al. Molecular basis of Thalassemia Syndromes in Serbia and Montenegro. Acta Haematol 2005; 113:175-180.
27. Stojiljkovic M, Jovanovic J, Djordjevic M, Grkovic S, Cvorkov Drazic M, Petrucev B, et al. Molecular and phenotypic characteristics of patients with phenylketonuria in Serbia and Montenegro. Clin Genet 2006; 70:151-155.
28. Gazouli M, Zacharatos P, Mantzaris G, Barbatis C, Ikonomopulos I, Archimandritis A, et al. Association of NOD2/Card 15 variants with Crohn's disease in a Greek population. Eur J Gastroenterol 2004; 16:1177-1182.
29. Stange EF, Travis SPL, Vermeire S, Beglinger C, Kupcinskas L, Geboes K, et al. European evidence based consensus on the diagnosis and management of Crohn's disease definition and diagnosis. Gut 2006; 55:1-15.
30. Satsangi J, Silvber MS, Vermeire S, Colombel J-F. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006; 55:749-753.
31. Stange EF, Travis SP The European consensus on ulcerative colitis: new horizons? Gut 2008; 57:1029-1031.
32. Giachino D, Van Duist MM, Regazzoni S, Gregori D, Bardessono M, Salacone P, et al. Analysis of the CARD15 variants R702W, G908R and L1007fs in Italian IBD patients. Eur J of Hum Gen 2004; 12:206-212.
33. Lala S, Ogura Y, Osborne C, Hor SY, Bromfield A, Davies S, et al. Crohn's disease and Nod 2 gene: a role for paneth cell. Gastroenterology 2003; 125:47-57.
34. Ahmad T, Armuzzi A, Bunce M, Mulcahy-Hawes K, Marshall SE, Orchard TR, et al. The molecular classification of the clinical manifestation of Crohn's disease. Gastroenterology 2002; 122:867-874.
35. Hampe J, Grebe J, Nikolaus S, Solberg C, Croucher PJ, Mascherati S, et al. Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study. Lancet 2002; 359:1661-1665.
36. Vermeire S, Wild G, Kocher K, Cousinaeu J, Dufresne L, Bitton A, et al. CARD 15 genetic variation in a Quebec population: prevalence, genotype- phenotype relationship, and haplotype structure. Am J Hum Genet 2002; 71:74-83.
37. Nagy Z, Karádi O, Rumi G, Rumi G Jr, Pár A, Mózsik G, et al. Crohn's disease is associated with polymorphism of Card 15/ NOD2 gene in a Hungarian population. Ann N Y Acad Sci 2005; 1051:45-51.
38. Annese V, Latino A, Andreoli A, Astegiano M, Bollani B, Campieri M, et al. Mutations of NOD 2 gene weakly correlate with Vienna classification of Crohn's disease (SD). Gastroenterology 2002; 122 (Suppl):A-296.
39. Cuthbert AP, Fisher SA, Mirza MM, King K, Hampe J, Croucher PJ, et al. The contribution of NOD gene mutation to the risk and the site of disease in inflammatory bowel disease. Gastroenterology 2002; 122:867-874.
40. Zhou Z, Lin XY, Akolkar PN, Gulwani-Akolkar B, Levine J, Katz S, Silver J. Variation at Card 15/ NOD2 in familial and sporadic cases of Crohn's disease in the Ashkenazi Jewish population. Am J Gastroenterol 2002; 97:3095-3101.
41. Polito JM, Childs B, Mellits D, Tokayer AZ, Harris ML, Bayless TM. Crohn's disease: influence of age at diagnosis on site and clinical type of disease. Gastroenterology 1996; 111:580-586.
42. Radlmayr M, Török HP, Martin K, Folwaczny C. The c-insertion mutation of NOD 2 gene is associated with fistulizing and fibrostenotic phenotypes in Crohn's disease. Gastroenterology 2002; 122:2091-2092.
43. Abreu MT, Taylor KD, Lin YC, Han T, Giaennie J, Landers CJ, et al. Mutations in NOD2 are associated with fibrostenoting disease in patients with Crohn's disease. Gastroenterology 2002; 123:679-688.
44. Hampe J, Cuthbert A, Croucher PJ, Mirza MM, Masheretti S, Fisher S, et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 2001; 357:1925-1928.
45. Louis E, Michel V, Hugot PJ, Reenaers C, Fontaine F, Delforge M, et al. Early development of structuring or penetrating pattern in Crohn's disease is influenced by disease location, number of flares, and smoking but not by NOD2/CARD15 genotype. Gut 2003; 52:552-557.
46. Vermeire S, Lois E, Rutgeerts P, De Vos M, Van Gossum A, Belaiche J, et al. NOD2/CARD 15 does not influence response to infliximab in Crohn's disease. Gastroenterology 2002; 123:106-111.
47. Masherattti S, Hampe J, Croucher PJ, Nikolaus S, Andus T, Schuber S, et al. Response to infliximab treatment in Crohn's disease is not associated with mutations in the Card 15(NOD2) gene: an analysis in 534 patients from two multicenter, prospective GCP-level trials. Pharmacogenetics 2003; 12:509-515.
48. Alvarez-Lobos M, Arostegui J, Sans M, Tassies D, Plaza S, Delgado S, et al. Crohn's disease patients carrying NOD2/CARD 15 gene variants have an increased and early need for first surgery due to stricturising disease and higher rate of surgical recurrence. Ann Surg 2005; 242:693-700.
49. Cho JH, Weaver CT. The genetics of inflammatory bowel disease. Gastroenterology 2007; 133:1327-1339.
50. Duerr RH. Update on the genetics of inflammatory bowel disease. J Clin Gastroenterol 2003; 37:358-367.
51. Gasche C, Grundtner P. Genotypes and phenotypes in Crohn's disease: do they help in clinical management? Gut 2005; 54:162-167.
52. Murillo L, Crusius JB, van Bodegraven AA, Alizadeh BZ, Peña AS. CARD15 gene and classification of Crohn's disease. Immunogenetics 2002; 54:59-61.